Peptide drug discovery at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

14 organizations at PEGS Europe 2026 present work in peptide drug discovery: 7 academic, government and non-profit bodies, 4 drug developers and 3 suppliers and service providers. Between them they bring 42 presentations to the program. Most represented: AstraZeneca (12 on the program), Novo Nordisk (4 on the program), Adimab (3 on the program). As of Oct 8, 2026.

All 541 organizations at PEGS Europe 2026 →

Showing 1–10 of 14 organizations

Organization	PEGS Europe 2026 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company with oncology, immunology, respiratory and rare disease medicines, including antibodies and ADCs.	Talk Tue Nov 17 9:30am–10:00am Building the Protein Lab of the Future at AstraZeneca: Automation First Science and AI Ready Data at Scale Leveraging Data Science for Enhanced Protein Expression Chair Tue Nov 17 11:44am–11:45am Chairperson's Remarks Display of Biologics Chair Tue Nov 17 2:00pm–2:05pm Chairperson's Remarks Display of Biologics Talk Tue Nov 17 5:20pm–5:50pm Machine Learning for Lead Optimisation Workflow (MeLLOw): Integrating in silico and Wet Lab Data for Biologics Engineering Optimisation & Developability Panel Tue Nov 17 5:50pm–6:20pm BEST PRACTICES FOR IN SILICO DESIGN OF ANTIBODIES: What We Know Now Display of Biologics · with Specifica, Merck KGaA, Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) Talk Tue Nov 17 5:50pm–6:20pm Engineering Affinity Attenuated and Effector CD8 Biased T Cell Engagers T Cell Engagers Chair Wed Nov 18 8:25am–8:30am Chairperson’s Remarks Machine Learning for Protein Engineering Part 1 Talk Wed Nov 18 11:15am–11:45am Stability Prediction for Multispecific Antibodies Machine Learning for Protein Engineering Part 1 Talk Wed Nov 18 11:45am–12:15pm Application of Expression Strategies for Integral Membrane Protein Production Designing High-Performance Expression Platforms Chair Thu Nov 19 8:25am–8:30am Chairperson's Remarks Highly Parallel Protein Discovery Workflows Talk Thu Nov 19 8:30am–8:50am Evolutionary Algorithms for Peptide Design and Optimisation Novel Peptide Drug Discovery Talk Thu Nov 19 9:00am–9:30am Next-Generation Protein Characterisation: An Integrated Mass Spectrometry Strategy from Structured Proteins to Intrinsically Disordered Proteins Highly Parallel Protein Discovery Workflows Talk Thu Nov 19 11:15am–11:45am Targeting Peptides for Enhanced Tissue Delivery Novel Peptide Drug Discovery Talk Thu Nov 19 11:45am–12:05pm AI for Biologics: Transition from Discovery to Design Machine Learning for Protein Engineering Part 2 Talk Thu Nov 19 5:15pm–5:45pm Optimal Design of Masks for Protease-Activated Biologics: What Works, What Doesn’t, and Why Next-Generation Immunotherapies
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Danish pharmaceutical company known for diabetes and obesity medicines, with in-house protein and peptide drug discovery.	Talk Tue Nov 17 9:00am–9:30am IVTT-Accelerated Protein Discovery: Generating Fit-for-Purpose AI Training Data Leveraging Data Science for Enhanced Protein Expression Talk Wed Nov 18 6:30pm–7:00pm High-Throughput Automation Platform for Miniaturised Biophysical Assays: Accelerating Compound Screening with One Click Analytical Characterisation of Biotherapeutics Talk Thu Nov 19 8:50am–9:10am Long Acting, Stable Urocortin-2 Analogues for the Treatment of Obesity and Diabetes Novel Peptide Drug Discovery Talk Thu Nov 19 2:05pm–2:35pm Real-World Progress, Challenges, and Opportunities for AI in Protein and Peptide Discovery Novel Peptide Drug Discovery
Adimab Lebanon, NH
adimab.com Discovery platforms Discovers and engineers antibodies and bispecifics for drug developers through partnerships, using a yeast display platform.	Talk Wed Nov 18 11:15am–11:44am Developability Profiling, Off-Target Screening, and CDR Engineering to De-Risk Therapeutic Antibodies Advancing Multispecific Antibodies and Combination Therapy to the Clinic Talk Wed Nov 18 7:00pm–7:30pm TCR Constant Region-Targeting VHH Bispecifics: An NHP Cross-Reactive Alternative to CD3 T Cell Engagers Advances in Immunoengineering Chair Thu Nov 19 2:00pm–2:05pm Chairperson's Remarks Novel Peptide Drug Discovery
GSK London, UK
	Talk Tue Nov 17 9:00am–9:30am Modelling Biparatopic Antibody Target Engagement and Pharmacology Optimisation & Developability Talk Wed Nov 18 9:00am–9:30am Methods and Technologies for Customisable Protein Expression in CHO Cells Designing High-Performance Expression Platforms Chair Thu Nov 19 10:44am–10:45am Chairperson's Remarks Novel Peptide Drug Discovery
University of Southampton Southampton, UK
	Talk Wed Nov 18 9:30am–10:00am Antibody Properties That Control Immune Receptor Signalling: Lessons from Affinity, Rigidity, and Geometry Engineering Antibodies & Beyond Chair Wed Nov 18 2:00pm–2:05pm Chairperson's Remarks Engineering Antibodies & Beyond · with IQS – Universitat Ramon Llull Talk Thu Nov 19 4:15pm–4:45pm Platforms for the Intracellular Generation and High-Throughput Screening of Cyclic Peptide Libraries Novel Peptide Drug Discovery Talk Thu Nov 19 4:45pm–5:15pm A "Function-First" Approach to Identify Regulatory T Cell-Targeting Antibodies for Immunotherapy Antibodies Against Challenging Targets
Cradle	◆Premier Sponsor
cradle.bio Software & AIPremier Sponsor Software company offering machine learning tools that help scientists design and optimise proteins, including antibodies and enzymes.	Talk Wed Nov 18 3:05pm–3:35pm Talk Title to be Announced Machine Learning for Protein Engineering Part 1 Talk Thu Nov 19 3:05pm–3:20pm Talk Title to be Announced Novel Peptide Drug Discovery
EPFL Lausanne, Switzerland
	Talk Tue Nov 17 11:45am–12:15pm Nanobody Discovery with AI-designed Soluble Analogues of Membrane Proteins Leveraging Data Science for Enhanced Protein Expression Talk Thu Nov 19 2:35pm–3:05pm Developing Membrane-Permeable Cyclic Peptides for Targeting Intracellular Proteins and for Oral Applications Novel Peptide Drug Discovery
University of Oslo Oslo, Norway
	Chair Thu Nov 19 8:25am–8:30am Chairperson's Remarks Machine Learning for Protein Engineering Part 2 Talk Thu Nov 19 9:10am–9:30am A New Technology for Endotoxin Removal from Biologicals and from Patient Blood Novel Peptide Drug Discovery
University of Texas at Austin Austin, TX
	Talk Wed Nov 18 2:05pm–2:35pm Validation and Analysis of 12,000 AI-Driven CAR-T Designs in the Bits to Binders Competition Machine Learning for Protein Engineering Part 1 Chair Thu Nov 19 8:25am–8:30am Chairperson's Remarks Novel Peptide Drug Discovery
Cornell University Ithaca, NY
	Talk Thu Nov 19 10:45am–11:14am Intracellular Delivery of Proteome-Modulating Peptides and Proteins Novel Peptide Drug Discovery Panel Thu Nov 19 3:35pm–4:15pm Strategies and Challenges for Intracellular Delivery of Peptides and Proteins Novel Peptide Drug Discovery